CRUK Cambridge Centre: CTYA Cancers
banner
crukcamctya.bsky.social
CRUK Cambridge Centre: CTYA Cancers
@crukcamctya.bsky.social
24 followers 92 following 130 posts
Posting about CTYA cancers research, education and events from the Childhood, Teenage and Young Adult Cancers Programme at the @crukcamcentre.bsky.social. Find out more at: www.crukcc.org/ctya
Posts Media Videos Starter Packs
Reposted by CRUK Cambridge Centre: CTYA Cancers
🎗This September @crukcamctya.bsky.social have shared research & patient stories shaping the future of childhood, teenage & young adult cancer care in Cambridge. Want to see more?

Explore highlights 👉 zurl.co/k9IGU
#ChildhoodCancerAwarenessMonth #CCAM25
🎗️ Show your support: Fundraisers and donations to @cancerresearchuk.org go directly into research that changes young lives, including here at the CTYA programme in Cambridge. Find out how to help: buff.ly/kArsrSl
Survival for childhood cancer is rising: now over 84% in England live at least 5 years after diagnosis. Let’s keep pushing for 100%. We can all help give more children the chance to grow up. Stay inspired and follow updates from us, @cancerresearchuk.org and @crukcamcentre.bsky.social
🎗️ Thank you for supporting #ChildhoodCancerAwarenessMonth and following our @crukcamcentre.bsky.social updates from the last year! You can find everything we have shared on our website > buff.ly/hxvGWCu
If you're interested in contributing to research that truly makes a difference, consider joining our Patient and Public Involvement (PPI) network. buff.ly/fs7QDSJ
The event enabled connections between researchers, health care providers and the families outside of medical settings.
This year, the event was hosted at Jesus College in July, it brought together young patients and their families for day of activities aimed at supporting the wellbeing and development of the young patients, who are either undergoing or who have recently completed their treatment.
As part of our PPI activities, the @crukcamcentre.bsky.social supported the annual Paediatric Oncology Activity Day organised by the paediatric haematology and oncology team at Addenbrooke’s Hospital @cuh.nhs.uk . buff.ly/8bsvYLK
Whether you’re a patient, caregiver, or simply passionate about improving care, Join the PPI network today and help us shape the future of childhood cancer research. Your voice is powerful! buff.ly/fs7QDSJ
When patients and carers are in the room—not just as participants but as partners—research becomes more relevant, inclusive, and impactful. That’s the heart of public involvement in childhood cancer research.
From research updates to urgent calls for data sharing, accessible info, and targeted funding, this meeting showed what real partnership looks like. Families and researchers are co-driving progress in ALCL care and science.
These “mumcologists”—parents turned experts—shared their deep knowledge of ALCL, helping shape research priorities. A young adult patient highlighted how 16–25s often fall between care systems. Their voices are not just valid—they’re vital.
An example of PPI in CTYA cancer: spotlighting the power of collaboration. In Cambridge, mums, researchers, and a young adult patient met in person for the first time to talk about a rare cancer - Anaplastic Large Cell Lymphoma (ALCL). buff.ly/W1frJTx
A global meeting of minds | CRUK CC
On Friday 27 June 2025, mothers, researchers, and a young adult patient came together for the first time in person in Cambridge.These mums and patient, who have formed a supportive online network…
crukcambridgecentre.org.uk
Reposted by CRUK Cambridge Centre: CTYA Cancers
📢 Today is the first ever #CancerCachexiaAwarenessDay!

Cachexia is a wasting syndrome that causes people with cancer to lose weight & muscle even when eating normally. Find out more on the @cancerresearchuk.org ➡️ zurl.co/kxTa3
If you’re a patient, family member, or caregiver, your experience can help guide the future of childhood cancer research. Join the PPI network today! buff.ly/fs7QDSJ
forms.office.com
Patients and their families bring important perspectives that help researchers understand how cancer treatment affects their lives. By involving young patients in research, we find solutions that not only treat the cancer but also improve overall well-being.
PPI - Public and Patient Involvement - is especially vital in childhood, teenage, and young adult cancer research. These groups have unique needs, and involving them in the research process helps us create solutions that are tailored to their experiences.
Research is not just about labs and data—it’s about people. Patients and the public play a crucial role in shaping the future of cancer treatment. At @crukcamcentre.bsky.social, we put a priority on partnering with those affected by cancer to ensure research is aligned with real-world needs.
Reposted by CRUK Cambridge Centre: CTYA Cancers
In Cambridge, patients & families are co-driving childhood cancer research – shaping priorities & ensuring it meets real-world needs. 🙌

Join our PPI network 👉 zurl.co/A4msb or email [email protected]
#ChildhoodCancerAwarenessMonth #CCAM25 @crukcamctya.bsky.social
This research calls for more effective, less toxic cancer treatments that minimize collateral damage to healthy tissues. Protecting young patients from long-term side effects is crucial for improving quality of life after treatment.
Chemotherapy can cause premature aging effects in blood cells, similar to natural aging. This is a concern for children, as they are especially vulnerable to long-term effects due to their developing bodies.
The study shows that certain chemotherapy drugs cause significant mutations in healthy blood cells, which could lead to long-term health issues. This highlights the need for therapies that target cancer cells while protecting healthy tissue.
A recent study sheds light on the long-term effects of chemotherapy on healthy blood cells, revealing that treatment can induce mutations and accelerate aging in blood cell populations. These findings are crucial for improving treatments for children with cancer. buff.ly/FsuUp0V
The long-term effects of chemotherapy on normal blood cells - Nature Genetics
Mutational signature analysis of blood cells isolated from 23 chemotherapy-exposed samples and 9 nonexposed controls characterizes the effects of various drugs on mutational burden, signature…
doi.org